OPG-dependent promotion of chemoresistant cancer stem cells was confirmed by showing that while OPG upregulation enhanced the resistance of BC cells to cisplatin and docetaxel, OPG downregulation enhanced the sensitivity of TNBC cells to these chemotherapeutic drugs (Fig. 8). This evidence concerns the gene TNFRSF11B and cancer.